A Simple Key For SITUS JUDI MBL77 Unveiled
translocations or amplifications on top of the genomic alterations now existing in the original CLL, but lack the widespread mutations observed in primary DLBCL indicating they could correspond to a special biological group.gene in patients relapsing right after therapy Using the BCL2 antagonist venetoclax. sixty six Resistance to these agents has